RealFakeLies
Trending CLM-5312A602

AI-extracted claim

“The FDA has approved the naloxone nasal spray Narcan for over-the-counter sale.”

Analyzed on 2026-09-22T01:40:06+00:00 · Last updated 2026-09-22

Unverified (Unverified)

Plain language: Insufficient evidence was found to render a verdict.

Credibility score

out of 100

Based on 1 source

Low confidence

01

Original context

Show passage from source article
Narcan, the nasal spray version of naloxone, has received F.D.A. approval to be sold over the counter.

Extracted from: Sailors Admit to Dealing Fentanyl-Laced Pills on U.S.S. Abraham Lincoln , The New York Times

02

Evidence

1 support 0 contradict 0 context

This analysis is based on a single source. Confidence is low.

The New York Times nytimes.com credibility 0.85 Supports

“Narcan, the nasal spray version of naloxone, has received F.D.A. approval to be sold over the counter.”

Sailors Admit to Dealing Fentanyl-Laced Pills on U.S.S. Abraham Lincoln

Bias distribution of supporting sources

← Left Center Right →

Mean bias -0.20

05

Community Takes

No Takes have been written on this claim yet. Sign in to write a Take.

06

Metadata

Claim ID CLM-5312A602
Slug the-fda-has-approved-the-naloxone-nasal-spray-narcan-for-ove-5312a602
Origin nytimes.com
Captured 4 d ago
Velocity 0.0/hr
Bias 0.00
Health Regulation FDA